Archives of Clinical Infectious Diseases

Published by: Kowsar

Microbiological and Minimum Inhibitory Concentration Study of Ventilator-associated Pneumonia Agents in Two University-associated Hospital Intensive Care Units in Mazandaran

Ahmad Alikhani 1 , Narges Najafi 1 , * , Alireza Davoudi 1 , Samaneh Tiroum 2 , Mohammad Reza Khademloo 3 , Mohammad Ebrahim Tayyebi 1 , Arman Shoujaiifar 4 and Mahmood Doudangeh 4
Authors Information
1 Department of Infectious Diseases, Antimicrobial Resistant Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Mazandaran University of Medical Sciences, Sari, IR Iran
3 Department of Social Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
4 Laboratory of Microbiology, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: December 24, 2012, 8 (1); 8-13
  • Published Online: December 24, 2012
  • Article Type: Research Article
  • Received: September 24, 2012
  • Revised: October 8, 2012
  • Accepted: November 5, 2012
  • DOI: 10.5812/archcid.16034

To Cite: Alikhani A, Najafi N, Davoudi A, Tiroum S, Khademloo M R, et al. Microbiological and Minimum Inhibitory Concentration Study of Ventilator-associated Pneumonia Agents in Two University-associated Hospital Intensive Care Units in Mazandaran, Arch Clin Infect Dis. 2012 ; 8(1):8-13. doi: 10.5812/archcid.16034.

Copyright © 2012, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir Care. 2005; 50(6): 714-21[PubMed]
  • 2. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med. 2003; 31(10): 2544-51[DOI][PubMed]
  • 3. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4): 388-416[DOI][PubMed]
  • 4. Coffin SE, Klompas M, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29-40[DOI][PubMed]
  • 5. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest. 2006; 130(1): 251-60[DOI][PubMed]
  • 6. Dodek P, Keenan S, Cook D, Heyland D, Jacka M, Hand L, et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med. 2004; 141(4): 305-13[PubMed]
  • 7. Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL, et al. Care of the ventilator circuit and its relation to ventilator-associated pneumonia. Respir Care. 2003; 48(9): 869-79[PubMed]
  • 8. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, CDC , Healthcare Infection Control Practices Advisory Committee , et al. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004; 53: 1-36[PubMed]
  • 9. Craven DE, Steger KA. Hospital-acquired pneumonia: perspectives for the healthcare epidemiologist. Infect Control Hosp Epidemiol. 1997; 18(11): 783-95[PubMed]
  • 10. Mayhall CG. Nosocomial pneumonia: diagnosis and prevention. Infect dis clin N Am. 1997; 11(2): 427-57
  • 11. Bonten MJM, Bergmans DCJJ. Hospital Epidemiology and Infection Control. 1999; : 211–38
  • 12. Wu CL, Yang DIe, Wang NY, Kuo HT, Chen PZ. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest. 2002; 122(2): 662-8[PubMed]
  • 13. Heyland DK, Cook DJ, Marshall J, Heule M, Guslits B, Lang J, et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest. 1999; 115(4): 1076-84[PubMed]
  • 14. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Internal Med. 2001; 134(4): 298-314
  • 15. Strausbaugh LJ. Principles and practice of infectious diseases. 2005; : 3363
  • 16. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000; 162(2 Pt 1): 505-11[DOI][PubMed]
  • 17. EUCAST Steering Committee Meeting 3-4 April 2007;
  • 18. Augustyn B. Ventilator-associated pneumonia: risk factors and prevention. Crit Care Nurse. 2007; 27(4): 32-9[PubMed]
  • 19. van Nieuwenhoven CA, Buskens E, Bergmans DC, van Tiel FH, Ramsay G, Bonten MJ. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units. Crit Care Med. 2004; 32(1): 126-30[DOI][PubMed]
  • 20. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000; 132(8): 621-30[PubMed]
  • 21. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006; 129(5): 1210-8[DOI][PubMed]
  • 22. Barclay L, Vega C. Ventilator-associated Pneumonia linked to worse outcomes in critically ill children. Pediatrics. 2009;; 123: 1108–15
  • 23. Lambiase A, Rossano F, Piazza O, Del Pezzo M, Catania MR, Tufano R. Typing of Pseudomonas aeruginosa isolated from patients with VAP in an intensive care unit. New Microbiol. 2009; 32(3): 277-83[PubMed]
  • 24. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006; 44(11): 3883-6[DOI][PubMed]
  • 25. Japoni A, Vazin A, Davarpanah MA, Afkhami Ardakani M, Alborzi A, Japoni S, et al. Ventilator-associated pneumonia in Iranian intensive care units. J Infect Dev Ctries. 2011; 5(4): 286-93[PubMed]
  • 26. Haque NZ, Zuniga LC, Peyrani P, Reyes K, Lamerato L, Moore CL, et al. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia. Chest. 2010; 138(6): 1356-62[DOI][PubMed]
  • 27. de Carvalho RH, Gontijo Filho PP. Epidemiologically relevant antimicrobial resistance phenotypes in pathogens isolated from critically ill patients in a Brazilian Universitary Hospital. Braz J Microbiol. 2008; 39(4): 623-30[DOI][PubMed]
  • 28. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32(8): 470-85[DOI][PubMed]
  • 29. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection. 2003; 31(4): 208-15[PubMed]
  • 30. Laboratory detection of imipenem or meropenem resistance in gram-negative organisms.
  • 31. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother. 2007; 51(4): 1553-5[DOI][PubMed]
  • 32. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis. 2004; 8(1): 25-79[PubMed]
  • 33. Mendes C, Oplustil C, Sakagami E, Turner P, Kiffer C. Antimicrobial susceptibility in intensive care units: MYSTIC program Brazil 2002. Braz J Infect Dis. 2005; 9(1): 44-51[PubMed]
  • 34. European Antimicrobial Resistance Surveillance System annual report. 2008;
  • 35. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007; 13(8): 1144-9[DOI][PubMed]
  • 36. Meyer E, Serr A, Schneider C, Utzolino S, Kern WV, Scholz R, et al. Should we screen patients for extended-spectrum beta-lactamase-producing enterobacteriaceae in intensive care units? Infect Control Hosp Epidemiol. 2009; 30(1): 103-5[DOI][PubMed]
  • 37. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004; 42(3): 1089-94[PubMed]
  • 38. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care. 2010; 14(3)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments